Our Promise to You

Guaranteed product quality, expert customer support

Our Promise to You

D13S319 Deletion Probe

  • Specification
  • Recommended Products
Cat.No.
FHPC-038
Description
Chromosomal abnormalities on chromosome 13q occur in 16 - 40% of multiple myeloma cases and are associated with poor prognosis. Deletions affecting the 13q14 band are also the most frequent genetic abnormalities of B-cell Chronic Lymphocytic Leukaemia. Two non-coding RNA genes, DLEU1 and DLEU2 and the genetic marker D13S319 span the pathogenic critical region 13q14.3. DLEU1 is considered to be the most likely CLL-associated candidate tumour suppressor gene within the 13q14 region. Subsequently the locus D13S319, located between the RB1 gene and D13S25 and within the DLEU1 locus, was found to be deleted in 45% of CLL cases. The D13S319 deletion probe covers the marker and the centromeric end of the DLEU1 locus.
Size
5 Tests, 10 Tests
Label
Red/Green
Locus
13q14.3
Specificity
Human
Usage
warningFor Research Use Only. Not for use in diagnostic procedures.
Storage
Store at minus 20 centigrade
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

For research use only. Not for any other purpose.

  • Q & A
  • Customer Review

Ask a Question

Write your own review

Customer Support & Price Inquiry

Verification Code